ABEO insider plans sale of 69,832 shares

Abeona Therapeutics (ABEO) insider Vishwas Seshadri has filed a notice of proposed stock sales under Rule 144.

Rhea-AI Filing Summary

Abeona Therapeutics (ABEO) insider Vishwas Seshadri has filed a notice of proposed stock sales under Rule 144. The filing covers 69,832 shares of common stock to be sold through Stifel Nicolaus & Company on the Nasdaq exchange, with an aggregate market value of 372,267.00. The filing notes that 54,191,361 shares of common stock were outstanding.

The securities to be sold were acquired on 01/21/2026 as 158,811 restricted stock units from the issuer, characterized as equity compensation, with the payment date listed as 01/22/2026. The document also reports that Seshadri sold 25,000 shares of common stock on 12/29/2025, generating gross proceeds of 132,740.00 over the prior three months.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ABEO shares does Vishwas Seshadri plan to sell under this Form 144 notice?

The notice states that 69,832 shares of Abeona Therapeutics common stock are planned to be sold through Stifel Nicolaus & Company on the Nasdaq exchange, with an aggregate market value of 372,267.00.

What is the total number of Abeona Therapeutics (ABEO) shares outstanding referenced in the Form 144?

The filing reports that 54,191,361 shares of Abeona Therapeutics common stock were outstanding, providing context for the planned sale amount.

How did Vishwas Seshadri acquire the ABEO shares listed for sale in this Form 144?

The Form 144 shows that the securities were acquired as restricted stock units from the issuer on 01/21/2026, in a transaction described as equity compensation, with the payment date listed as 01/22/2026.

What prior ABEO stock sales by Vishwas Seshadri are disclosed in the last 3 months?

The filing discloses that 25,000 shares of Abeona Therapeutics common stock were sold on 12/29/2025, generating gross proceeds of 132,740.00 over the past three months.

Which broker is handling the planned ABEO share sale in this Form 144?

The document lists Stifel Nicolaus & Company Inc., located at 501 N Broadway, St. Louis, MO 63102, as the broker for the planned sale of Abeona Therapeutics common stock on Nasdaq.

What is the approximate date of the planned ABEO stock sale in the Form 144?

The Form 144 indicates an approximate sale date of 01/22/2026 for the planned disposition of 69,832 shares of Abeona Therapeutics common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/22/2026 - 04:08 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001865131
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ABEONA THERAPEUTICS INC.
SEC File Number	001-15771
Address of Issuer	6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OHIO 44103
Phone	646-813-4701
Name of Person for Whose Account the Securities are To Be Sold	Seshadri Vishwas
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	69832	372267.00	54191361	01/22/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	01/21/2026	Restricted Stock Units	Issuer			158811	01/22/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Vishwas Seshadri 6555 Carnegie Ave Fl 4 Cleveland OH 44103	Common Stock	12/29/2025	25000	132740.00

144: Remarks and Signature

Remarks	The shares were sold to cover for taxes pursuant to an RSA vesting event.
Date of Notice	01/22/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Luca Lotito, as a duly authorized representative of STIFEL, as attorney-in-fact for Vishwas Seshadri
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)